Insiders · Profile

Rottinghaus Scott T.

Chief Medical Officer at ENANTA PHARMACEUTICALS. Filing since 5 Dec 2023. CIK 0001942407

Company
Date
Role
Action
Shares
Amount
Of holding
5 Dec 2025
Chief Medical Officer
Sold at will
798
$11.36K
3.5%
6 Dec 2024
Chief Medical Officer
Sold on a plan
866
$6.98K
4.6%
15 Jul 2024
Chief Medical Officer
Sold on a plan
5,375
$91.81K
19.8%
12 Jul 2024
Chief Medical Officer
Sold on a plan
2,271
$34.16K
9.5%
11 Jul 2024
Chief Medical Officer
Sold on a plan
4,299
$64.79K
15.2%
5 Dec 2023
Sr. VP & CMO
Sold at will
534
$5.14K
2.0%
6 decisions on file.